Skip to main content
. 2019 Jul 31;2(2):78–83. doi: 10.1016/j.jimed.2019.07.005

Fig. 2.

Fig. 2

Kaplan-Meier curves for overall survival (A), and progression-free survival (B). SoraOXA group = sorafenib plus hepatic arterial infusion of oxaliplatin. Sorafenib group = Sorafenib monotherapy group.